Word

PACTIMMUNE

Status

Dead

Status Code

606

Status Date

Monday, March 20, 2023

Serial Number

90815371

Mark Type

4000

Filing Date

Wednesday, July 7, 2021

Published for Opposition

Tuesday, December 21, 2021

Abandoned Date

Monday, March 20, 2023

Trademark Owner History

PACT Pharma, Inc. - Owner At Publication

Classifications

42 Immune cell-based genetic analysis services for scientific research and development purposes; immune cell-based genetic screening for scientific research and development purposes; immune cell-based genetic testing for scientific research purposes; medical and scientific immune cell-based research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing medical and scientific immune cell-based research information in the field of clinical trials; providing medical and scientific immune cell-based research information in the fields of pharmaceuticals and immune cell genetics; scientific research in the field of immune cell-based genetics and genetic engineering; Providing medical testing services in the field of cancer research and disease classification at the molecular level; Laboratory services provided to generate immune cell receptor data for research and the development of diagnostic tests; providing medical diagnostic and prognostic testing services; scientific research and development services; providing an online computer database in the field of immune cell genetics

PACT IMMUNE

Trademark Events

Mar 20, 2023

Abandonment Notice E-Mailed - No Use Statement Filed

Mar 20, 2023

Abandonment - No Use Statement Filed

Aug 13, 2022

Notice Of Approval Of Extension Request E-Mailed

Aug 11, 2022

Sou Extension 1 Granted

Aug 11, 2022

Sou Extension 1 Filed

Aug 11, 2022

Teas Extension Received

Feb 15, 2022

Noa E-Mailed - Sou Required From Applicant

Dec 21, 2021

Official Gazette Publication Confirmation E-Mailed

Dec 21, 2021

Published For Opposition

Dec 1, 2021

Notification Of Notice Of Publication E-Mailed

Nov 12, 2021

Approved For Pub - Principal Register

Nov 12, 2021

Examiner's Amendment Entered

Nov 12, 2021

Notification Of Examiners Amendment E-Mailed

Nov 12, 2021

Examiners Amendment E-Mailed

Nov 12, 2021

Examiners Amendment -Written

Oct 5, 2021

Notification Of Non-Final Action E-Mailed

Oct 5, 2021

Non-Final Action E-Mailed

Oct 5, 2021

Non-Final Action Written

Sep 27, 2021

Assigned To Examiner

Sep 15, 2021

New Application Office Supplied Data Entered

Jul 10, 2021

New Application Entered